P 569
| Code | Size | Price |
|---|
| TAR-T33853-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
P 569 is an MRI contrast medium.
CAS:
136880-97-2
Formula:
C17H22I3N3O9
Molecular Weight:
793.088
Purity:
0.98
SMILES:
OCCNC(=O)c1c(I)c(N(CC(O)CO)C(=O)C(O)CO)c(I)c(C(=O)NCO)c1I
References
Violon D. Analysis of the factors influencing the osmolality of eight monomeric nonionic iodinated contrast medium molecules. Invest Radiol. 1997 Nov;32(11):684-9. PubMed PMID: 9387056.
Li K, Miller C, Hegde S, Wojchowski D. Roles for an Epo receptor Tyr-343 Stat5 pathway in proliferative co-signaling with kit. J Biol Chem. 2003 Oct 17;278(42):40702-9. Epub 2003 Aug 9. PubMed PMID: 12909618.
Dai Y, Li C, Zhang F, Yang J, Chang S, Lu H, Yang H, Huang Z, Qian J, Ge L, Ge J. Safety and Efficacy of Percutaneous Coronary Intervention via Transradial Versus Transfemoral Approach in Bypass Grafts. Angiology. 2018 Feb;69(2):136-142. doi: 10.1177/0003319717711765. Epub 2017 Jun 12. PubMed PMID: 28602142.
Zelichowska B, Rekas M, Stankiewicz A, Cervi?o A, Mont?s-Mic? R. Apodized diffractive versus refractive multifocal intraocular lenses: optical and visual evaluation. J Cataract Refract Surg. 2008 Dec;34(12):2036-42. doi: 10.1016/j.jcrs.2008.06.045. PubMed PMID: 19027556.